Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MedCap AB ( (SE:MCAP) ) just unveiled an announcement.
MedCap AB, a Swedish healthcare-focused group, reported a strong first quarter for 2026, driven by higher sales and improved profitability across its operations. The company continues to emphasize EBITA and margin performance as key indicators of its value-creation strategy within specialized healthcare segments.
Net sales rose 13 percent year-on-year to SEK 556.6 million, while EBITA increased 32 percent to SEK 109.6 million, lifting the EBITA margin to 19.7 percent from 16.8 percent. Profit after tax reached SEK 55.7 million and earnings per share climbed to SEK 3.7, underscoring robust operational leverage, although operating cash flow dipped slightly to SEK 51.7 million compared with the prior year.
More about MedCap AB
MedCap AB is a Swedish public company that operates a group structure, focusing on specialized healthcare-related products and services. The company targets niche segments where it can combine organic growth and acquisitions to build leading positions, with profitability measured primarily through EBITA and margin development.
Average Trading Volume: 15,073
Technical Sentiment Signal: Hold
Current Market Cap: SEK7.37B
For detailed information about MCAP stock, go to TipRanks’ Stock Analysis page.